New science, drug regulation, and emergent public health issues: The work of FDA’s division of applied regulatory science

The U.S. Food and Drug Administration (FDA) Division of Applied Regulatory Science (DARS) moves new science into the drug review process and addresses emergent regulatory and public health questions for the Agency. By forming interdisciplinary teams, DARS conducts mission-critical research to provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Kimberly, Racz, Rebecca, Burkhart, Keith, Florian, Jeffry, Ford, Kevin, Iveth Garcia, M., Geiger, Robert M., Howard, Kristina E., Hyland, Paula L., Ismaiel, Omnia A., Kruhlak, Naomi L., Li, Zhihua, Matta, Murali K., Prentice, Kristin W., Shah, Aanchal, Stavitskaya, Lidiya, Volpe, Donna A., Weaver, James L., Wu, Wendy W., Rouse, Rodney, Strauss, David G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893027/
https://www.ncbi.nlm.nih.gov/pubmed/36743666
http://dx.doi.org/10.3389/fmed.2022.1109541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893027/
https://www.ncbi.nlm.nih.gov/pubmed/36743666
http://dx.doi.org/10.3389/fmed.2022.1109541

Ejemplares similares